December 2018 The results of the 2018 MTF survey, released today (December 17), contain a mix of encouraging news and warning signals. Notably, the survey this year contained a major shock: a stunning rise in use of nicotine in vaping devices since 2017. Read More.
November 2018 World AIDS Day, is a good time to reflect on some of the spectacular successes of NIH-funded science at reducing the impact of HIV, as well as how lessons learned in the fight against HIV/AIDS can be applied to other pressing health issues such as addiction. Read More.
October 2018 With the passing of Herbert Kleber on October 5, the field of addiction research has lost a true giant—one of its biggest thinkers as well as one of the most articulate and effective advocates for compassionate, scientifically informed treatment. Read More.
October 2018 Medication is a crucial part of treating addiction—but by itself, a pill or an injection may not be sufficient. Social support has long been known to be an important factor in a variety of recovery programs and treatment approaches. Read More.
September 2018 Nicotine does not produce the kind of euphoria or impairment that many other drugs like opioids and marijuana do. People do not get high from smoking cigarettes or vaping. Yet nicotine’s powerful ability to reinforce its relatively mild rewards results in 480,000 deaths annually. Read More.
September 2018 The public health emergency of opioid misuse and addiction affects millions of Americans and requires innovative scientific solutions. Today, during “National Prescription Opioid and Heroin Awareness Week,” we are sharing news of an important step towards these solutions through the HEALing Communities Study. Read More.
August 2018 Ample evidence shows methadone and buprenorphine reduce overdose deaths, prevent the spread of diseases like HIV, and enable people to take back their lives, but there are restrictions on who can prescribe these medications. Read More.
July 2018 This week, the Food and Drug Administration (FDA) approved Epidiolex (cannabidiol, or CBD), a medication extracted from marijuana, for the treatment of two severe pediatric seizure disorders. Read More.